New research shows that we might be closer to discovering a cure for cancer. It turns out that the protocol might have been under our noses for a while now. Researchers are now looking into whether or not it is possible to use a commonly used diabetes medication in the battle against cancer.
The drug Metformin is traditionally used for controlling the blood sugar of people who have type 2 diabetes. The American Association for Cancer Research (AACR) held a study that shows that Meformin (a.k.a. Fortamet, Glucophage, Glumetza and Riomet) can help men who struggle with prostate cancer. For these men, the drug slows down the growth of tumor cells. Other studies on the use of this drug as a cancer fighter have been released by the AACR. New research might be able to prove that metformin can fight pancreatic cancer.
Professionals like Jose Baselga, MD, PhD, Chief of Hematology/Oncology at Massachusetts General Hospital are not immediately jumping on the Metformin bandwagon. Baselga believes that the drug shows signs of producing an anti-cancer effect, but he also cautions us against getting ahead of ourselves. He is right when stating that the drug is still in its early stages of cancer testing, so there is much more information to be detected in this fight.
In the study, the 22 men involved had some tissue sampled the day that they got their diagnosis and also 41 days after that, when they had their prostates removed. Metformin slowed the growth of their tumors by 32 percent. Right now the study is small and many of the pros agree that more research is needed before it is determined that the treatment might work. We might be a step closer to discovering the cure for cancer, which makes this very good news.